Eye drops may offer a new way to read without glasses — a trial puts them to the test
Symptom relief
Completed
This phase 3 trial tests whether CTO0307, a pilocarpine eye drop, can improve near vision in adults aged 40 to 64 with presbyopia — the age-related difficulty seeing up close. Participants receive either the active drop or a placebo for four weeks. The main question is whether mo…
Phase: PHASE3 • Sponsor: Taejoon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC